Efficacy and Safety of Talsaclidine (Free Base) in Patients With Mild to Moderate Dementia of Alzheimer Type

TRx0014 in Patients With Mild or Moderate Alzheimer's Disease

NCT00515333 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety of PRJ212 to Improve the Memory of Patients With Mild Severity Alzheimer's Disease

NCT02991235 ·Status: UNKNOWN ·Phase: NA

The Effect of Cognitive Function as Measured by Repeated Cognitive Measures After 12 Weeks Treatment With Donepezil

NCT01024660 ·Status: COMPLETED ·Phase: EARLY_PHASE1

Clinical Study Evaluating Efficacy and Safety of T3D-959 in Mild-to-moderate AD Subjects

NCT04251182 ·Status: COMPLETED ·Phase: PHASE2

Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease

NCT01689246 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of AD-35 in Treatment of Subjects With Mild to Moderate Alzheimer's Disease

NCT03625401 ·Status: UNKNOWN ·Phase: PHASE2

Cerebrolysin Compared to Donepezil in Patients With Mild to Moderate Dementia of Alzheimer's Type (DAT)

NCT01822951 ·Status: WITHDRAWN ·Phase: PHASE4

A Study Of PF-04447943 Compared To Placebo In Subjects With Mild To Moderate Alzheimer's Disease

NCT00930059 ·Status: COMPLETED ·Phase: PHASE2

Efficacy, Safety and Tolerability of Tideglusib to Treat Mild-to-Moderate Alzheimer's Disease Patients

NCT01350362 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate the Effects of MK-0249 and an Alzheimer's Disease Medication on Cognitive Function in Adults With Alzheimer's Disease (MK-0249-023)

NCT00874939 ·Status: TERMINATED ·Phase: PHASE1

Safety, Tolerability and Efficacy Study to Evaluate Subjects With Mild Cognitive Impairment

NCT00422981 ·Status: COMPLETED ·Phase: PHASE2

Study Evaluating The Safety Of AAB-003 (PF-05236812) In Subjects With Alzheimer's Disease

NCT01193608 ·Status: COMPLETED ·Phase: PHASE1

An Evaluation of Three Doses of NS 2330 in Patients With Mild to Moderate Dementia of the Alzheimer's Type

NCT00153010 ·Status: COMPLETED ·Phase: PHASE2

A Dose Ranging Study To Investigate The Efficacy And Safety Of SB-742457 In Alzheimer's Disease

NCT00224497 ·Status: COMPLETED ·Phase: PHASE2

Bridging Study With GSK239512 In Patients With Mild To Moderate Alzheimer's Disease

NCT00675090 ·Status: COMPLETED ·Phase: PHASE1

Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease

NCT00663936 ·Status: COMPLETED ·Phase: PHASE2

Study of LM11A-31-BHS in Mild-moderate AD Patients

NCT03069014 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Evaluate the Efficacy and Safety of ID1201 for Dose-finding in Mild Alzheimer's Disease

NCT03363269 ·Status: COMPLETED ·Phase: PHASE2

Impact of Nilotinib on Safety, Biomarkers and Clinical Outcomes in Mild to Moderate Alzheimer's Disease

NCT02947893 ·Status: COMPLETED ·Phase: PHASE2

Clinical Pharmacology of p38 MAP Kinase Inhibitor, VX-745, in Mild Cognitive Impairment Due to Alzheimer's Disease (AD) or Mild AD

NCT02423200 ·Status: COMPLETED ·Phase: PHASE2

Study to Evaluate the Safety, Tolerability and Efficacy of CT1812 in Subjects With Mild to Moderate Dementia With Lewy Bodies

NCT05225415 ·Status: COMPLETED ·Phase: PHASE2

Safety and Efficacy of TRx0237 in Subjects With Alzheimer's Disease Followed by Open-Label Treatment

NCT03446001 ·Status: COMPLETED ·Phase: PHASE3

A Safety and Tolerability Study of JNJ-54861911 in Participants With Early Alzheimer's Disease

NCT02260674 ·Status: COMPLETED ·Phase: PHASE2

A Pilot Open Labeled Study of Tacrolimus in Alzheimer's Disease.

NCT04263519 ·Status: WITHDRAWN ·Phase: PHASE2

A Randomized, Double-blind, Placebo-controlled, Sequential Ascending, Single-dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of E2212 in Healthy Subjects

NCT01221259 ·Status: COMPLETED ·Phase: PHASE1